Oxford Nanopore Technologies (LSE:ONT) Research & Development: £97.7 Mil (TTM As of Dec. 2025)


LSE:ONT Oxford Nanopore Technologies PLC LSE:ONT
74 GF Score
Price £1.24
GF Value £1.87
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Oxford Nanopore Technologies Research & Development?

Oxford Nanopore Technologies LSE:ONT +2.31% 74 Research & Development is £97.7 Mil as of Dec. 2025. GuruFocus rates LSE:ONT with a GF Score™ of 74/100 and a GF Value™ of £1.87 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Oxford Nanopore Technologies's Research & Development for the six months ended in Dec. 2025 was £53.6 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was £97.7 Mil.

Oxford Nanopore Technologies  (LSE:ONT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Oxford Nanopore Technologies Research & Development Related Terms

Oxford Nanopore Technologies Research & Development Historical Data

* Premium members only.

The historical data trend for Oxford Nanopore Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oxford Nanopore Technologies Research & Development Chart

Oxford Nanopore Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 75.98 69.19 103.84 98.90 97.70

Oxford Nanopore Technologies Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.61 48.00 50.90 44.10 53.60
LSE:ONT
74GF Score
Oxford Nanopore Technologies PLC LSE:ONT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oxford Nanopore Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £97.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £97.7 Mil mean?
Oxford Nanopore Technologies (LSE:ONT) has a Research & Development of £97.7 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Oxford Nanopore Technologies and its competitors.
Is Oxford Nanopore Technologies' Research & Development too high?
Oxford Nanopore Technologies' current Research & Development is £97.7 Mil. Overall, Oxford Nanopore Technologies has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Oxford Nanopore Technologies' Research & Development compare to VRTX and REGN?
Oxford Nanopore Technologies' Research & Development of £97.7 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Oxford Nanopore Technologies and its competitors. Oxford Nanopore Technologies's current Research & Development is £97.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford Nanopore Technologies stock overvalued right now?
Based on GuruFocus' analysis, Oxford Nanopore Technologies (LSE:ONT) is currently considered Significantly Undervalued. The stock's GF Value™ is £1.87, compared to a current price of £1.24 — trading 33.6% below its estimated fair value. The current Research & Development is £97.7 Mil. Oxford Nanopore Technologies' overall GF Score™ is 74/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Oxford Nanopore Technologies (LSE:ONT), the current Research & Development is £97.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oxford Nanopore Technologies (LSE:ONT) Overvalued in 2026?

Based on GuruFocus' analysis, Oxford Nanopore Technologies stock appears to be undervalued. The current stock price of £1.24 is trading 33.6% below its estimated GF Value™ of £1.87. GuruFocus considers Oxford Nanopore Technologies to be Significantly Undervalued.

Key valuation signals for LSE:ONT:

  • Research & Development: £97.7 Mil
  • GF Value™: £1.87 vs. price of £1.24 (33.6% below fair value)
  • GF Score™: 74/100 with 2 warning signs

No single metric tells the full story. See the LSE:ONT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oxford Nanopore Technologies Business Description

Address Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX4 4DQ
Oxford Nanopore Technologies PLC is involved in researching, developing, manufacturing and commercializing deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that provides rich data, is fast, accessible and easy to use, and which allows the real-time analysis of DNA or RNA. It has developed and brought to market a new generation molecular sensing platform based on nanopores. The first application is DNA/RNA sequencing and the platform is also being developed for the analysis of proteins and metabolites. It operates in single segment of providing products and services related to the sale and use of its nanopore-based sensing technology. Geographically its operations are spread across EMES, AMR, and APAC.
74GF Score

Get the complete analysis for LSE:ONT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£1.24
Price
£1.87
GF Value